Profile
Richard A. Morgan is currently the Director at the American Society of Gene & Cell Therapy.
Prior to this, he was the Senior Vice President-Immunogenetics at Editas Medicine, Inc. from 2018 to 2021.
He received his undergraduate degree from Brandeis University and his doctorate from The Johns Hopkins University.
Richard A. Morgan active positions
| Companies | Position | Start |
|---|---|---|
American Society of Gene & Cell Therapy
American Society of Gene & Cell Therapy Miscellaneous Commercial ServicesCommercial Services Operates as medical and professional organization that represents researchers and scientists devoted to the discovery | Director/Board Member | - |
Former positions of Richard A. Morgan
| Companies | Position | End |
|---|---|---|
| EDITAS MEDICINE, INC. | Corporate Officer/Principal | 2021-01-31 |
Training of Richard A. Morgan
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Brandeis University
Brandeis University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Johns Hopkins University
The Johns Hopkins University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Editas Medicine, Inc.
Editas Medicine, Inc. BiotechnologyHealth Technology Manufactures gene editing medicines | Health Technology |
American Society of Gene & Cell Therapy
American Society of Gene & Cell Therapy Miscellaneous Commercial ServicesCommercial Services Operates as medical and professional organization that represents researchers and scientists devoted to the discovery | Commercial Services |
- Stock Market
- Insiders
- Richard A. Morgan
















